Ascorbic Acid Versus Diode Laser in the Treatment of Gingival Hyperpigmentation
NCT ID: NCT03252418
Last Updated: 2017-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
10 participants
INTERVENTIONAL
2015-10-07
2016-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Oxidant Gel and Anti-oxidant Gel on Wound Healing After Gingival Depigmentation
NCT05837416
Diode Low-power Laser Before In-office Bleaching
NCT05865275
Comparative Evaluation of Microsurgery vs Diode Laser Technique of Gingival Depigmentation
NCT05930366
Gingival Depigmentation by Diode Laser
NCT02143375
Effects of Desensitizing Dentifrices on the Reduction of Pain Sensitivity Caused by In-office Dental Whitening
NCT03019224
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This randomized comparative clinical study was conducted on ten patients attending the outpatient clinic of the Oral Medicine and Periodontology department, Faculty of Dentistry, Ain Shams University and seeking treatment for their gingival hyperpigmentation for esthetic reason.
The study was conducted after receiving an ethical clearance from the Research Ethics Committee of Ain Shams University, Faculty of Dentistry; that the study follows the ethical guidelines of research. The patients clearly understood the purpose of this study and signed an informed consent.
According to the study results, vit C treated patients showed no or little repigmentation after six months post treatment. Conversely, diode laser treated patients showed significant recurrence of gingival pigmentation after six months post treatment. These could be attributed to the blocking effect of vitamin C on the existing melanocytes to form new melanoseomes, however diode laser cause removal of the existing melanocytes that may cause formation of new melanocytes (migrating from neighboring melanocytes from the adjacent area of the gingiva) with the ability of forming new melanosomes and causing repigmentation. Histopathological assessment revealed that both treatment modalities caused significant reduction in MAF after six months post treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ascorbic acid
injection of 1 ml intamucosal ascorbic acid 3 times with 1 week interval
Ascorbic Acid 500 MG
ascorbic acid is vitamin that can cause gingival depigmentation
diode laser
photothermolysis by diode laser in one session
diode laser
diode laser is soft tissue laser case photothermolysis of melanoctes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ascorbic Acid 500 MG
ascorbic acid is vitamin that can cause gingival depigmentation
diode laser
diode laser is soft tissue laser case photothermolysis of melanoctes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Bilaterally symmetric gingival hyperpigmentation on the maxillary and mandibular labial keratinized gingiva between canines.
* Patients free from any systemic diseases as evidenced by the health questionnaire, using modified Cornell medical index (Pendleton et al., 2004).
* Patients with thick gingival biotype ≥ 3 mm.
Exclusion Criteria
* Smokers.
* Pregnant or lactating females.
* Patients with poor oral hygiene, incompliance to treatment and persistence gingival inflammation after phase I periodontal therapy.
* Clinically diagnosed periodontitis (attachment and bone loss, presence of periodontal pockets, gingival recession and tooth mobility).
* Previous treatment to pigmentation.
* Patients taking supplementary vitamin C for any reason.
* Known sensitivity to ascorbic acid or any of its derivatives.
* Patients taking any drug that may cause gingival pigmentation.
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dalia Yosri
Assistant lecturer of oral medicine and periodontology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nevine H kheir ElDien, Professor
Role: STUDY_DIRECTOR
faculty of Dentistry- Ain Shams univesity
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FDASU-RECIM10201512
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.